Skip to main content
Signal8

EOM Pharmaceuticals Holdings, Inc. (IMUC)

EOM Pharmaceuticals Holdings, Inc., a clinical-stage biotechnology company, focuses on the development of drugs to transform therapeutic paradigms and enhance quality of life in patients suffering from debilitating and deadly diseases in the United States. The company’s lead compound is EOM613, a peptide nucleic-acid solution with both anti-inflammatory and pro-inflammatory broad spectrum cytokine effects that has completed Phase 2 clinical trials for the treatment of cancer cachexia, AIDS/cancer cachexia, HIV/AIDS, and rheumatoid arthritis, as well as in Phase ½ a clinical trial to treat infectious diseases, such as COVID-19. It also develops EOM 147, an investigational broad-spectrum aminosterol with an intracellular mechanism that has completed Phase 2 clinical trial for the treatment of age-related macular degeneration, diabetic retinopathy, and macular edema due to retinal vain occlusion. EOM Pharmaceuticals Holdings, Inc. was founded in 2020 and is headquartered in Montvale, New Jersey.

Sector: Biotechnology

Industry: Biotechnology

EOM Pharmaceuticals Holdings, Inc. logo

EOM Pharmaceuticals Holdings, Inc.

OTC:IMUCHealthcare
-0.19%$0.1575
CLOSED
Mkt Cap$19.92M
EV-
Float112.95M
O/S126.5M
VOL6K sh
$ Vol$402
RVOL1.80×
Inst Own-
SI<0.1%
Net Cash/Sh-
Dilution
EOM Pharmaceuticals Holdings, Inc. logoOTC:IMUCClosed$0.1575-0.19%
Short interest (FINRA)
0.0%
Oct 30 (18d)

Float 112.95M · FMP free float

40
Oct 30 (18d)prev 40– 0.0%
1.00
Oct 30 (18d)prev 1.00– 0.0%
Borrow (IBKR)

The cost to borrow IMUC shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
85.5%
Nov 3 (14d)prev 100.0%▼ 14.5 pts

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

No fails on record for 16–31 Oct 2026.
Price, short interest & fails to deliver
Short interest · today's share basis23 settlements
Latest short interest settlements (today's share basis)
DateShares short
Oct 30, 202640 sh
Oct 15, 202640 sh
Sep 30, 202640 sh
Sep 15, 202640 sh
Aug 31, 202640 sh

The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.

Off-exchange short volume
Nov 3
Latest sessions
DateReported short
Nov 3, 202685.5%
Oct 27, 2026100.0%
Oct 6, 202644.8%
Sep 29, 202621.1%
Sep 15, 202695.2%
7-session median 74.0%mean 70.0%range 21.1–100.0%

130 calendar days requested; 8 sessions published. FINRA reports this at T+1 to T+2, so the latest session is not today's.

Source: FINRA Reg SHO daily short volume, summed across the NASDAQ, NYSE and Consolidated trade reporting facilities. Covers off-exchange (over-the-counter) executions only; volume executed on an exchange is not included and is not reported short here.

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for IMUC: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually

As of the Oct 30, 2026 FINRA settlement, 40 IMUC shares were sold short (<0.01% of a 112.95M-share float, 1.00 days to cover).